Early experience of thoracic endovascular aortic repair: a local single hospital experience.
10.4174/jkss.2012.82.5.302
- Author:
Kyung Yun KIM
1
;
Seung Jae BYUN
;
Kyeong Ho YUN
;
Sam Youn LEE
;
Dae Woong RYU
;
Sang Jae RHEE
;
Byung Jun SO
Author Information
1. Department of Vascular Surgery, Wonkwang University School of Medicine & Hospital, Iksan, Korea. polarisking@hanmail.net
- Publication Type:Original Article
- Keywords:
Stent graft;
TEVAR;
Thoracic aneurysm;
Traumatic thoracic injury
- MeSH:
Aneurysm;
Aneurysm, False;
Aorta, Thoracic;
Aortic Diseases;
Arm;
Endoleak;
Follow-Up Studies;
Humans;
Ischemia;
Length of Stay;
Retrospective Studies;
Ulcer
- From:Journal of the Korean Surgical Society
2012;82(5):302-305
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: The purpose of this retrospective study was to evaluate the short- to mid-term results of thoracic endovascular aortic repair (TEVAR) in Wonkwang University School of Medicine & Hospital. METHODS: Between February 2009 and May 2011, 8 consecutive patients had undergone endovascular stent-grafting for thoracic aortic diseases. Five patients were treated for traumatic thoracic aortic injuries, two patients were treated for thoracic aneurysms and one patient was treated for a pseudoaneurysm due to penetrating aortic ulcers. Attempted stent-graft deployment was performed electively in 6 patients and emergently in 2. Follow-up was performed at 1-month, 6-month, 1-year, and annually thereafter. RESULTS: Technical success rates were achieved in 87.5% and the 30-day mortality rate was 0%. Mean hospital length of stay after TEVAR was 30 days in traumatic thoracic aortic injuries and 10 days in thoracic aneurismal diseases. Intra-operative Type I endoleak due to migration at deflation was visualized in 1 patient, which was treated by insertion of another stent-graft. During follow-up, a major complication was encountered in one patient who received carotid-subclavian bypass to relieve left arm ischemia. After 5 months he was treated with arch replacement for aortic arch aneurysm with type I endoleak at proximal site after endovascular treatment. The 30-day mortality rate was 0%. However, 1 case of mortality (12.5%) was observed during the follow-up period. CONCLUSION: The short and mid-term results of endovascular repair of thoracic aortic diseases are promising. TEVAR is an effective procedure in the management of thoracic aortic diseases.
